Nazione: Irlanda
Lingua: inglese
Fonte: HPRA (Health Products Regulatory Authority)
CARPROFEN
Krka, d.d., Novo mesto
QM01AE91
CARPROFEN
50 Mg/Ml
Solution for Injection
POM
Canine, Feline
Carprofen
N.S.A.I.D
Authorised
2014-07-11
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Rycarfa 50 mg/ml solution for injection for dogs and cats 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each ml contains: ACTIVE SUBSTANCE: Carprofen 50 mg EXCIPIENT: Benzyl alcohol 10 mg For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Solution for injection. Clear, pale yellow coloured solution. 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Dogs and cats. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES Dogs: For the control of post-operative pain and inflammation following orthopaedic and soft tissue (including intraocular) surgery. Cats: For the control of post-operative pain following surgery. 4.3 CONTRAINDICATIONS Do not use in animals suffering from cardiac, hepatic or renal disease or gastrointestinal problems, where there is a possibility of gastrointestinal ulceration or bleeding, or hypersensitivity to carprofen or any other NSAIDs or any excipients of this product. Do not administer by intramuscular injection. Do not use after surgery which was associated with considerable blood loss. Do not use in cats on repeated occasions. Do not use in cats less than 5 months of age. Do not use in dogs less than 10 weeks of age. See also section 4.7. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES None. HEALTH PRODUCTS REGULATORY AUTHORITY ________________________________________________________________________________________________________________________ _Date Printed 15/07/2014_ _CRN 7014748_ _page number: 1_ 4.5 SPECIAL PRECAUTIONS FOR USE Special precautions for use in animals Do not exceed the recommended dose or duration of treatment. Due to the longer half life in cats and narrower therapeutic index, particular care should be taken not to exceed the recommended dose and the dose should not be repea Leggi il documento completo